DBVT today
$11.88+$0.37 (+3.21%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minStrong Bullish
5 minStrong Bullish
Daily trend turns up above $12.21
Key levels
Resistance$13.09
Resistance$12.21
Support$10.86
Support$9.92
Latest news & SEC filings
AnalystGuggenheim keeps Buy rating on DBV Technologies, cuts price target
AnalystGuggenheim keeps Buy rating on DBV Technologies, cuts price target to $46
AnalystCitizens keeps Market Outperform on DBV Technologies, cuts target to $47
All DBVT news →About DBV Technologies
DBV Technologies is a clinical-stage biopharmaceutical company developing a skin-patch immunotherapy platform called Viaskin. Its lead candidate, Viaskin Peanut, is being studied as a treatment for peanut allergy in young children, with additional programs in milk allergy and eosinophilic esophagitis. The company operates in the United States and Europe, targeting patients, caregivers, and allergists.
Based on the company's 10-K filed Mar 26, 2026.
Nasdaq · Healthcare
DBV Technologies S.A. (DBVT)
What Is the Price Target for DBVT?
SEPT Low Target
$46.00
SEPT Mid Target
$47.00
SEPT High Target
$51.00
Analyst Consensus
$47.00
Is DBVT a Buy or Sell Right Now?
Thesis
- •Revenue growing 35.8% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DBVT.
Start Free Trial →Is DBVT Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$47.00
23
Moat Score
NONE
4/9
Piotroski Score
8.1
Altman Z-Score
What Is Smart Money Doing with DBVT?
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →DBVT Growth Story
Revenue YoY
35.8%
3yr Revenue CAGR
5.2%
EPS Growth YoY
10.26%
FCF Growth YoY
-13.9%
Revenue Trend
STRONG
Dark Pool Trades for DBVT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for DBVT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:59:05 | $11.94 | 3,000 | $$36K | SELL |
| 20:44:15 | $11.85 | 7,000 | $$83K | BUY |
| 20:43:41 | $11.79 | 7,000 | $$83K | SELL |
| 20:42:52 | $11.78 | 8,400 | $$99K | SELL |
| 20:42:30 | $11.84 | 3,900 | $$46K | BUY |
5 dark pool trades shown · $$346K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for DBV Technologies S.A. (DBVT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →DBVT — frequently asked questions
What is DBVT stock price today?
DBV Technologies S.A. (DBVT) is at $11.88, up 3.21% (+$0.37) at the Nov 11, 2026 close.
Why is DBVT stock moving today?
Latest DBVT news — Oct 30, 2026: Guggenheim keeps Buy rating on DBV Technologies, cuts price target · Oct 30, 2026: Guggenheim keeps Buy rating on DBV Technologies, cuts price target to $46
What is the DBVT price target?
The average analyst price target for DBVT is $47.00, ranging from $46 to $51, based on 3 analysts. Latest: Guggenheim maintains on Oct 30, 2026.
What do analysts rate DBVT?
Analyst ratings for DBVT: 0 Buy, 8 Hold, 0 Sell — consensus Hold.
Did DBVT beat earnings?
DBVT last reported on Oct 28, 2026: EPS -$0.70 vs -$0.29 expected — a miss of 141.5%.
Does DBVT pay a dividend?
DBVT does not currently pay a dividend.
How much debt does DBVT have?
DBV Technologies S.A. reported $0M of debt and $166M of cash (Sep 30, 2026).
What are DBVT support and resistance levels?
Support: $10.86, $9.92, $8.93. Resistance: $12.21, $13.09, $13.97.
What are insiders doing with DBVT?
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.
What is the latest news on DBVT?
Oct 30, 2026: Guggenheim keeps Buy rating on DBV Technologies, cuts price target · Oct 30, 2026: Guggenheim keeps Buy rating on DBV Technologies, cuts price target to $46 · Oct 29, 2026: Citizens keeps Market Outperform on DBV Technologies, cuts target to $47